Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $99,986,000 | reported | |
| FY 2024 | 2024-12-31 | $79,906,000 | reported | |
| FY 2023 | 2023-12-31 | $65,421,000 | reported | |
| FY 2022 | 2022-12-31 | $45,520,000 | reported | |
| FY 2021 | 2021-12-31 | $45,183,000 | reported | |
| FY 2020 | 2020-12-31 | $41,138,000 | reported |
NeuroPace Inc · CIK 1528287 · Engraved from SEC EDGAR
Twelve months to Jun 30, 2026 · derived
NeuroPace Inc is the 49th largest of the 147 covered companies the SEC files under this code, by revenue. SIC 3841
Latest filing Sep 25, 2026
The us-gaap concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $49.55M | $49.55M | $0.00 | 33.67M sh | +3.4% | — |
| FY2024 | — | $0.00 | $0.00 | $0.00 | 32.56M sh | +14.9% | — |
112 managers · Quarter ended Jun 30, 2026All holders ›
171 transaction